◆ 会议时间：2025年11月2日至4日
◆ 会议地点：泰国 曼谷

◆ 会议简介：

2025年第20届亚太临床微生物与感染病学大会(APCCMI2025)暨第51届泰国感染病协会(IDAT)年会将于2025年11月2日至4日在泰国曼谷举行，会议由亚太临床微生物学与感染学会(APSCMI)与泰国感染病协会(IDAT)联合组织，APCCMI每两年召开一次。

APCCMI大会将展示临床微生物学、传染病学以及科学和医学的最新研究成果。大会议题将包括：感染控制、微生物和疫苗方面的进展，新的抗菌素和抗菌素管理；微生物学的进展，包括快速诊断、全基因组测序应用、实验室自动化；领域国际医学会议网译；人类以及在动物、人类和环境在同一健康背景下的抗菌素耐药性；艾滋病毒、疟疾和结核病这三种流行病感染面临的挑战和取得的进展；本区域流行的新发传染病(基孔肯雅热、登革热、寨卡病毒)和全球流行的禽流感和季节性流感、MERS-CoV；等等。会议期间将举行专家会议、主题演讲和全体会议，同时将举行多个区域宣和国际专家研讨会。预计将有亚洲各地的1000多名代表出席会议，大会还将举行最新的行业展览会，展示最新的药品和疫苗、实验室和科研设备以及感染控制技术。

亚太临床微生物学与感染学会(APSCMI)成立于20世纪80年代中期，是一个由35个成员协会组成的联合会，包括来自亚太主要国家(包括中国、印度、日本、印度尼西亚、马来西亚、澳大利亚等)的国家传染病学会。APSCMI的主要目标是：提高传染病患者的护理质量；促进亚太地区临床微生物学和感染病学的发展与进步；为该领域的专业人士提供一个交流经验和信息的平台；等等。未经许可禁止复制摘录转载本站任何内容-国际医学会议网（lingyuint.com）.

20th Asia Pacific Congress of Clinical Microbiology and Infection (APCCMI 2025)
51st Conference of the Infectious Diseases Association of Thailand (IDAT)

Dates: 2 - 4 November 2025
Venue: Bangkok, Thailand

Organized by:
Asia Pacific Society of Clinical Microbiology and Infection (APSCMI)
Infectious Diseases Association of Thailand (IDAT)

摘要征文投稿：

Important Dates

A late-breaking abstract should contain new information that was not yet known or fully available by the abstract submission deadline, 31 July 2025. The data in the abstract must not be published prior to the meeting. It should show data that is high-impact, innovative, and newsworthy. Please note that the late-breaking abstract deadline is not intended to be an extension of the regular abstract submission deadline.

Presenting Authors must register for the congress by no later than 15 October 2025 (BKK), and pay the registration fee in full by the registration deadline to secure their presence at the congress.

• Abstracts must be submitted online via the APCCMI 2025 website only. (Will be available soon.)
• Abstracts must contain original work that has not previously been reported
• Abstracts may be original research, case studies, or insight and review articles
• Only the presenting author may submit the abstract
• The abstract MUST NOT exceed 250 words, excluding the title, authors and affiliations
• Full papers are NOT required
• You MUST include results or data in your abstract - you may include figures and/or tables
• Abstracts that describe plans for a study or state “results will be presented” will NOT be accepted
• Do NOT include references
• Do NOT submit abstracts with typographical or grammatical errors
• All abbreviations should be given in brackets after the first full use of the word
• All presentations MUST be in English
• Authors can indicate their preferred presentation type from the following three options:
  • E-poster only
  • E-poster with rapid-fire presentation
  • Oral presentation
  Authors may select more than one option. However, the APCCMI 2025 Organizing Committee reserves the right to determine the final presentation format for all abstracts after review.
• Acknowledgment of submission will be sent automatically to both the abstract submitter and the presenting author by e-mail. Please contact the secretariat if the e-mail confirmation has not been sent.
• Modifications may be made at any time until the late-breaking abstract submission deadline of 28 August 2025 (23:59 BKK).
• All submitted abstracts will be reviewed by the APCCMI scientific committee according to the review process. Once APCCMI scientific committee completes to abstract review and professional editing, some of the authors would be asked to review within 7 days, only minor editing will be permitted.

• Include the following sub-headings: Aim, Background, Methods, Results, Conclusions
• Use font type Arial, with single spaced lines
• Title of the paper (size 10, font type Arial, bold, centered and capitalised) and is to be followed by one blank line
• Authors' names to be written (size 10, centered and capitalised) with initials followed by dot, family names to be written in full
• Authors to be separated by commas, presenting author marked with an asterisk, and individual authors marked with superscript number to distinguish the different affiliations
• Authors' affiliations (size 10, italic, centered) to be written on separate lines when there are more than one and the last to be followed by one blank line
• Abstract text (size 10) to be justified on middle; paragraphs are not to be indented, only separated by one blank line
• Please name your document as follows prior to submitting: Names of Authors (as per author format above) - Abstract Title
• Abstracts will NOT be reviewed if not in the specified format

Presenting authors must be registered participants. Only abstracts of authors who have paid their registration fees will be scheduled for presentation and included for publication.

• Bacterial infections
• Antimicrobial resistance
• Antibiotic/diagnostic stewardship
• New antimicrobial agents, pharmacology/pharmacogenetics
• Sepsis and systemic inflammatory response syndrome
• Culture-based diagnostics in clinical microbiology
• Serologic diagnosis and monitoring in infectious diseases
• Rapid diagnostics in clinical microbiology
• Performance evaluation and quality control in clinical microbiology
• Viral infections other than COVID-19
• COVID-19
• Fungal infections
• Medical parasitology
• Tuberculosis and nontuberculous mycobacterial infections
• Infection control and prevention
• Vaccine and immunology
• Public health and socioeconomic impact
• Microbiomes and metagenomics
• Big data and artificial intelligence in infectious disease
• Others

注册费：

Overseas Participants

◆ 参会对象：传染病科医生/科学家、临床和实验室微生物学家、药剂师，医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。